Durgical
EN
Open the app

Autoimmune encephalitis: psychiatry plus seizures plus movement

  • Syndrome

A young person with sudden psychosis, seizures and strange movements may have antibodies attacking the brain. Treated early, most recover.

Updated

See it in 3D: Hippocampus · Amygdala · Temporal lobe · Cingulate gyrus · Hypothalamus · Ovaries

What it is

Autoimmune encephalitis is brain inflammation driven by antibodies or T cells against neuronal proteins. Antibodies against cell-surface targets (NMDA receptor, LGI1, CASPR2, GABA-B receptor, AMPA receptor) cause memory loss, psychiatric change, seizures, movement disorders and reduced consciousness developing over days to weeks, and they respond well to immunotherapy. Antibodies against intracellular targets (Hu, Ma2 and others) mark paraneoplastic syndromes in which cytotoxic T cells kill neurons; these respond poorly and the tumour is the main target. Diagnosis combines the clinical picture with MRI, CSF and EEG, and antibody tests in serum and CSF; treatment should not wait for the antibody result.

How to recognise it

  • Onset over days to weeks of memory loss, altered mental state or psychiatric symptoms, plus new focal signs, unexplained seizures, CSF pleocytosis or MRI changes of encephalitis.
  • Psychiatric red flags: first psychosis with seizures, catatonia, dyskinesias, autonomic swings, reduced consciousness, or severe intolerance of antipsychotics.
  • MRI is normal in most anti-NMDA receptor cases; limbic encephalitis (LGI1, paraneoplastic) shows medial temporal T2 and FLAIR signal.
  • CSF shows mild lymphocytic pleocytosis or oligoclonal bands in many, but can be normal, especially in LGI1.
  • EEG shows slowing in most; extreme delta brush is a pattern suggesting anti-NMDA receptor encephalitis; look for seizures without visible convulsions.
  • CASPR2: muscle hyperexcitability, neuropathic pain and insomnia; GABA-B: severe seizures with small cell lung cancer; AMPA: limbic signs with thymoma, lung or breast cancer.
  • Intracellular paraneoplastic antibodies: Hu (small cell lung cancer), Ma2 (testicular tumours), Yo (ovarian and breast cancer, cerebellar degeneration).

Why it happens

  • Surface antibodies cross-link receptors and cause them to be taken into the cell (NMDA) or break up a synaptic protein complex (LGI1), reducing function without killing neurons.
  • Intracellular targets are hidden from antibodies; the antibody is a marker of a T-cell attack that kills neurons, so loss is permanent.
  • Tumours that make neural proteins (teratomas with neural tissue, small cell lung cancer, thymoma) break immune tolerance and start the response.

The main antibodies and their faces

AntibodyTypical patientCluesTumour to seekResponse to treatment
NMDA receptorYoung women, childrenPsychosis, dyskinesias, autonomic instability, hypoventilation, extreme delta brushOvarian teratomaGood, slow recovery over months
LGI1Men over 60Faciobrachial dystonic seizures, memory loss, low sodiumRarely a tumourGood if treated early
CASPR2Older menMuscle hyperexcitability, pain, insomnia, limbic signsSometimes thymomaGood
GABA-B receptorOlder adults, smokersSevere seizures, limbic encephalitisSmall cell lung cancerDepends on the tumour
Hu, Ma2 (intracellular)Adults with cancerLimbic and brainstem encephalitis, sensory neuronopathyLung, testisPoor; treat the tumour

Differential diagnosis

  • Herpes simplex encephalitis: fever, temporal lobe lesions, CSF HSV PCR; give aciclovir until it is excluded.
  • Primary psychiatric illness: no seizures, movement disorder, autonomic change, or CSF and EEG abnormalities.
  • Neuroleptic malignant syndrome: rigidity, fever and high CK after antipsychotics; patients with NMDA receptor encephalitis are prone to it and it can mimic the disease.
  • Others: prion disease (rapid dementia, myoclonus), metabolic and toxic encephalopathy, nonconvulsive status epilepticus, CNS vasculitis, lymphoma.

Next step

  • MRI with contrast, EEG (continuous if consciousness is reduced) and lumbar puncture with cells, protein, glucose, oligoclonal bands and HSV PCR.
  • Antibody panel in serum and CSF: NMDA receptor, LGI1, CASPR2, GABA-B, AMPA, GAD and onconeural antibodies.
  • Sodium, toxicology, HIV, syphilis and thyroid tests.
  • Tumour search: pelvic ultrasound or MRI for teratoma, CT of chest, abdomen and pelvis, testicular ultrasound, PET if negative and suspicion high.
  • First-line immunotherapy (corticosteroids, IVIG or plasma exchange); second-line (rituximab, cyclophosphamide) if no response; ICU for autonomic failure or hypoventilation.

Common traps

  • New psychosis in a young woman is always primary psychiatric illness: seizures, dyskinesias, catatonia, autonomic swings or poor tolerance of antipsychotics call for MRI, EEG, CSF and NMDA receptor antibodies.
  • Treatment waits for the antibody result: results take days to weeks, and once infection is excluded and herpes is covered, early immunotherapy improves outcome.
  • Normal MRI and CSF exclude autoimmune encephalitis: MRI is normal in most anti-NMDA receptor cases and CSF may be normal in LGI1.
  • Brief face and arm jerks are only a movement disorder: faciobrachial dystonic seizures are seizures of LGI1 encephalitis and respond better to immunotherapy than to antiseizure drugs alone.
  • A negative serum test rules it out: NMDA receptor antibodies may be found only in CSF, so test both.

Test yourself

Think of the answer, then tap the question to see it.

A 22-year-old woman has a week of headache, then paranoia, insomnia and a seizure; after an antipsychotic she becomes rigid, with lip-smacking movements and swinging blood pressure. What next?

Suspect anti-NMDA receptor encephalitis: EEG, MRI, CSF with antibodies in CSF and serum, pelvic imaging for teratoma, and early immunotherapy once infection is excluded.

A 68-year-old man has dozens of brief jerks of his face and arm each day, failing memory and low sodium. Why does recognising the jerks matter?

They are faciobrachial dystonic seizures of LGI1 encephalitis; immunotherapy at this stage stops them and can prevent the later cognitive impairment.

Why does anti-Hu encephalitis respond worse to immunotherapy than anti-NMDA receptor encephalitis?

Hu is intracellular: the antibody marks a T-cell attack that kills neurons, whereas NMDA receptor antibodies remove receptors from living neurons, which can recover.

Three weeks after treated herpes simplex encephalitis, a child develops writhing movements and irritability. What do you suspect?

Post-herpetic anti-NMDA receptor encephalitis rather than viral relapse: repeat CSF HSV PCR, but also test NMDA receptor antibodies and consider immunotherapy.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of neurology

Educational content; it does not replace supervised training, your institution's protocols or a medical assessment. It contains no doses. For signs of stroke (face drooping, arm weakness, speech trouble), a prolonged seizure or fever with a stiff neck, call the emergency number (123 in Colombia) or go to the nearest emergency department.

Sources: Autoimmune encephalitis: clinical presentation, investigation and treatment (Journal of Neurology (PubMed Central), 2021); Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients (Frontiers in Psychiatry (PubMed Central), 2017); Encephalitis: MedlinePlus Medical Encyclopedia (MedlinePlus (U.S. National Library of Medicine), 2025).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.